LS

Lokesh Sreedharan Muthathyan

Active Director Director DIN 10686027
DIN 10686027 First appointment Jun 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Lokesh Sreedharan Muthathyan

Data last updated:

Lokesh Sreedharan Muthathyan is a Director at Sai Krishna Healthcare Private Limited (since 2024). The company operates in Healthcare.

DIN 10686027
Primary Designation Director
Industry Healthcare
First Appointment 27 Jun 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Jun 20242024Active

Board colleagues of Lokesh Sreedharan Muthathyan

Directorship timeline

Open interactive timeline →
Sai Krishna Healthcare Private Limited
Premium access

Shareholding and investment profile for Lokesh Sreedharan Muthathyan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lokesh Sreedharan Muthathyan

Lokesh Sreedharan Muthathyan currently holds 1 directorship: Sai Krishna Healthcare Private Limited (Director, since 27 Jun 2024).

Lokesh Sreedharan Muthathyan was first appointed on 27 Jun 2024 as Director at Sai Krishna Healthcare Private Limited.

The current boards of Lokesh Sreedharan Muthathyan's companies include Leebin Sreedharan Muthathyan (Sai Krishna Healthcare Private Limited), Sreedharan Krishnan Muthathyan (Sai Krishna Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available